Thoracic wall fascial plane blocks (pectoral nerve and serratus anterior plane blocks) versus thoracic paravertebral block in patients undergoing breast surgery: a systematic review, meta-analysis and trial sequential analysis of analgesic effects

Abstract Background Thoracic wall fascial plane blocks, principally the pectoral nerve (PECS I/II) and serratus anterior plane (SAPB) blocks, and the thoracic paravertebral block (PVB) are both used to provide analgesia for breast surgery, but they have not been formally compared in a contemporary quantitative synthesis. We compared their effects on postoperative resting pain scores, 24 h morphine equivalent consumption, postoperative nausea and vomiting (PONV), time to first rescue analgesia and reported block-related complications. Methods Randomised controlled trials (RCTs) comparing a thoracic wall fascial plane block (FPB; PECS I, PECS II, SAPB or pecto-intercostal fascial block) with PVB in adults undergoing breast surgery were identified from PubMed, EMBASE, Google Scholar, the Cochrane Library and ClinicalTrials.gov to March 2025. Two investigators independently screened studies and extracted data. All continuous outcomes were expressed in clinically interpretable units (pain on a common 0–10 scale, opioid consumption as intravenous morphine equivalents in mg, and time to first rescue analgesia in hours) and were pooled as mean differences (MD) with 95% confidence intervals (CI); standardised mean differences (SMD) are reported as sensitivity analyses. Dichotomous outcomes were pooled as odds ratios (OR). Random-effects models used restricted maximum likelihood (REML) estimation of the between-study variance with the Hartung–Knapp adjustment, and 95% prediction intervals are reported alongside confidence intervals. Risk of bias was assessed with the Cochrane tool and certainty of evidence with GRADE. Subgroup analyses (PECS versus SAPB; mastectomy versus non-mastectomy surgery), sensitivity analyses excluding trials at high risk of bias, and trial sequential analyses (TSA) were performed. Results A total of 21 RCTs involving 1167 patients were included. Resting pain scores were lower after FPB than after PVB at 6 h [MD 0.50 points, 95% CI 0.14–0.85; I² = 75%], the only outcome to reach statistical significance in the revised primary analyses. At 0 h, a post hoc timepoint not listed in the registered protocol, the difference was no longer statistically significant once the Hartung–Knapp correction was applied [MD 0.41 points, 95% CI − 0.02–0.83; I² = 88%], whereas the original DerSimonian–Laird analysis had reached significance. Both point estimates lie below the 1.0-point threshold for a clinically important difference, and the 95% prediction intervals for both timepoints ( − 0.97–1.79 and −0.60–1.59 points) include no difference in either direction. No statistically significant differences were found in 24 h IV morphine equivalent requirements [MD 1.14 mg, 95% CI − 0.64–2.91], resting pain scores at 2 h [MD 0.30 points, 95% CI − 0.16–0.76], 12 h [MD 0.33 points, 95% CI − 0.26–0.93] or 24 h [MD − 0.20 points, 95% CI − 0.63–0.23], time to first rescue analgesia [MD − 1.73 h, 95% CI − 3.60–0.13], or PONV [OR 1.44, 95% CI 0.89–2.34]; for each of these outcomes the confidence interval crossed the null value, so the direction of any difference is uncertain. After exclusion of the five trials at high risk of bias, the difference at 6 h [MD 0.37 points, 95% CI − 0.06–0.80] was no longer statistically significant. Exploratory subgroup analyses suggested that the early differences were confined to PECS rather than SAPB trials, but only one of eight tests for subgroup interaction was statistically significant. After reassessment of imprecision against prespecified thresholds for clinically important benefit and harm, certainty of evidence was low for four outcomes (resting pain at 0, 2 and 6 h and PONV) and very low for the remaining four (24 h morphine equivalent consumption, resting pain at 12 and 24 h, and time to first rescue analgesia); no outcome was rated moderate or high. Pneumothorax was reported in two PVB patients and in no FPB patient, and no case of local anaesthetic systemic toxicity was reported. Conclusion Thoracic wall fascial plane blocks may be associated with slightly lower resting pain scores than PVB at 6 h, but the entire confidence interval lies below the 1.0-point threshold for a clinically important difference, so the evidence is compatible only with an effect too small to matter to patients; the certainty of this evidence is low, and the difference did not persist after exclusion of trials at high risk of bias. The apparent difference at 0 h did not survive an appropriate random-effects correction and arose at a post hoc timepoint. Trial sequential analyses are exploratory and do not indicate that these findings are unlikely to change with further evidence. No consistent differences were found in 24 h opioid consumption, later pain scores, time to first rescue analgesia or PONV. Exploratory subgroup analyses suggested possible differences between PECS and SAPB that require confirmation in adequately powered, standardised trials conducted within contemporary multimodal analgesia pathways. Available safety data were too sparse to establish comparative safety. Systematic review registration https://www.crd.york.ac.uk/prospero/ . (PROSPERO), identifier CRD 42024597114

Authors

Publication Details

Journal
BMC Anesthesiology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12871-026-04364-z
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Thoracic wall fascial plane blocks (pectoral nerve and serratus anterior plane blocks) versus thoracic paravertebral block in patients undergoing breast surgery: a systematic review, meta-analysis and trial sequential analysis of analgesic effects

Timothy Xianyi Yang, Keith Siu Kay Yeung, Alex Tze Kin Ng, Viki Yung et al.
BMC Anesthesiology
Anesthesia and Pain Management
article

Thoracic wall fascial plane blocks (pectoral nerve and serratus anterior plane blocks) versus thoracic paravertebral block in patients undergoing breast surgery: a systematic review, meta-analysis and trial sequential analysis of analgesic effects

Timothy Xianyi Yang, Keith Siu Kay Yeung, Alex Tze Kin Ng, Viki Yung, Karen Yuen Kiu Chow
article en

Abstract

Abstract Background Thoracic wall fascial plane blocks, principally the pectoral nerve (PECS I/II) and serratus anterior plane (SAPB) blocks, and the thoracic paravertebral block (PVB) are both used to provide analgesia for breast surgery, but they have not been formally compared in a contemporary quantitative synthesis. We compared their effects on postoperative resting pain scores, 24 h morphine equivalent consumption, postoperative nausea and vomiting (PONV), time to first rescue analgesia and reported block-related complications. Methods Randomised controlled trials (RCTs) comparing a thoracic wall fascial plane block (FPB; PECS I, PECS II, SAPB or pecto-intercostal fascial block) with PVB in adults undergoing breast surgery were identified from PubMed, EMBASE, Google Scholar, the Cochrane Library and ClinicalTrials.gov to March 2025. Two investigators independently screened studies and extracted data. All continuous outcomes were expressed in clinically interpretable units (pain on a common 0–10 scale, opioid consumption as intravenous morphine equivalents in mg, and time to first rescue analgesia in hours) and were pooled as mean differences (MD) with 95% confidence intervals (CI); standardised mean differences (SMD) are reported as sensitivity analyses. Dichotomous outcomes were pooled as odds ratios (OR). Random-effects models used restricted maximum likelihood (REML) estimation of the between-study variance with the Hartung–Knapp adjustment, and 95% prediction intervals are reported alongside confidence intervals. Risk of bias was assessed with the Cochrane tool and certainty of evidence with GRADE. Subgroup analyses (PECS versus SAPB; mastectomy versus non-mastectomy surgery), sensitivity analyses excluding trials at high risk of bias, and trial sequential analyses (TSA) were performed. Results A total of 21 RCTs involving 1167 patients were included. Resting pain scores were lower after FPB than after PVB at 6 h [MD 0.50 points, 95% CI 0.14–0.85; I² = 75%], the only outcome to reach statistical significance in the revised primary analyses. At 0 h, a post hoc timepoint not listed in the registered protocol, the difference was no longer statistically significant once the Hartung–Knapp correction was applied [MD 0.41 points, 95% CI − 0.02–0.83; I² = 88%], whereas the original DerSimonian–Laird analysis had reached significance. Both point estimates lie below the 1.0-point threshold for a clinically important difference, and the 95% prediction intervals for both timepoints ( − 0.97–1.79 and −0.60–1.59 points) include no difference in either direction. No statistically significant differences were found in 24 h IV morphine equivalent requirements [MD 1.14 mg, 95% CI − 0.64–2.91], resting pain scores at 2 h [MD 0.30 points, 95% CI − 0.16–0.76], 12 h [MD 0.33 points, 95% CI − 0.26–0.93] or 24 h [MD − 0.20 points, 95% CI − 0.63–0.23], time to first rescue analgesia [MD − 1.73 h, 95% CI − 3.60–0.13], or PONV [OR 1.44, 95% CI 0.89–2.34]; for each of these outcomes the confidence interval crossed the null value, so the direction of any difference is uncertain. After exclusion of the five trials at high risk of bias, the difference at 6 h [MD 0.37 points, 95% CI − 0.06–0.80] was no longer statistically significant. Exploratory subgroup analyses suggested that the early differences were confined to PECS rather than SAPB trials, but only one of eight tests for subgroup interaction was statistically significant. After reassessment of imprecision against prespecified thresholds for clinically important benefit and harm, certainty of evidence was low for four outcomes (resting pain at 0, 2 and 6 h and PONV) and very low for the remaining four (24 h morphine equivalent consumption, resting pain at 12 and 24 h, and time to first rescue analgesia); no outcome was rated moderate or high. Pneumothorax was reported in two PVB patients and in no FPB patient, and no case of local anaesthetic systemic toxicity was reported. Conclusion Thoracic wall fascial plane blocks may be associated with slightly lower resting pain scores than PVB at 6 h, but the entire confidence interval lies below the 1.0-point threshold for a clinically important difference, so the evidence is compatible only with an effect too small to matter to patients; the certainty of this evidence is low, and the difference did not persist after exclusion of trials at high risk of bias. The apparent difference at 0 h did not survive an appropriate random-effects correction and arose at a post hoc timepoint. Trial sequential analyses are exploratory and do not indicate that these findings are unlikely to change with further evidence. No consistent differences were found in 24 h opioid consumption, later pain scores, time to first rescue analgesia or PONV. Exploratory subgroup analyses suggested possible differences between PECS and SAPB that require confirmation in adequately powered, standardised trials conducted within contemporary multimodal analgesia pathways. Available safety data were too sparse to establish comparative safety. Systematic review registration https://www.crd.york.ac.uk/prospero/ . (PROSPERO), identifier CRD 42024597114

BMC Anesthesiology
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon